Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Rats had lasting erectile problems after stopping a certain medication.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Tamsulosin and finasteride have similar effects on blood sugar control in men with type 2 diabetes.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.